SUPPLEMENTAL APPENDIX: THE MDS-003 STUDY INVESTIGATORS

Baer M, Roswell Park Cancer Institute, Buffalo, NY, USA; Bennett J, University of Rochester, Rochester, NY, USA; Curtin P, Oregon Health and Science University, Portland, OR, USA; Deeg HJ, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Dewald G, Mayo Clinic, Rochester, MN, USA [deceased]; Dreisbach L, Desert Hematology Oncology, Rancho Mirage, CA, USA; Feldman E, Cornell Medical Center, New York, NY, USA; Fonseca G, Cancer and Blood Disease Center, Lecanto, FL, USA; Giagounidis A, St Johannes Hospital, Duisberg, Germany; Gordon M, Arizona Cancer Center, Scottsdale, AZ, USA; Gore S, Johns Hopkins School of Medicine, Baltimore, MD, USA; Gotlib J, Stanford Cancer Center, Stanford, CA, USA; Greenberg P, Stanford University, Stanford, CA, USA; Hermann R, Northwest Georgia Oncology, Marietta, GA, USA; Ifthikharuddin J, James P. Wilmot Cancer Center, Rochester, NY, USA; Knight R, Celgene Corporation, Summit, NJ, USA; Larson R, University of Chicago Medical Center, Chicago, IL, USA; Lian E, Sylvester Cancer Center, Miami, FL, USA; List A, University of South Florida College of Medicine and H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Maness L, University of Nebraska Medical Center, Omaha, NE, USA; Moreno A, Mayo Clinic, Jacksonville, FL, USA; Nimer S, Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Patin J, Celgene Corporation, Warren, NJ, USA; Raza A, University of Massachusetts, Worcester, MA, USA; Powell B, Wake Forest University, Winston-Salem, NC, USA; Reeder C, Mayo Clinic, Scottsdale, AZ, USA; Schmidt M, Celgene Corporation, Warren, NJ, USA; Sekeres M, Cleveland Clinic Foundation, Cleveland, OH, USA; Shadduck R, Western Pennsylvania Cancer Institute, Pittsburgh, PA, USA; Shammo J, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL, USA; Silverman L, Mt. Sinai Medical Center, New York, NY USA; Stone R, Dana-Farber Cancer Institute, Boston, MA, USA; Thomas D, M.D. Anderson Cancer Center, Houston, TX, USA; Wride K, Celgene Corporation, Warren, NJ, USA; Zeldis J, Celgene Corporation, Warren, NJ, USA.

1